{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:13:13Z","timestamp":1762013593138,"version":"build-2065373602"},"reference-count":115,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neurol.2018.11.007","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:35:19Z","timestamp":1558719319000},"page":"495-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Seizures in patients with a phaeochromocytoma\/paraganglioma (PPGL): A review of clinical cases and postulated pathological mechanisms"],"prefix":"10.1016","volume":"175","author":[{"given":"Y.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2018.11.007_bib0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizure and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neurol.2018.11.007_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(02)00012-8","article-title":"Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizure in C57BL\/6 and CD -1 mice","volume":"49","author":"Shibley","year":"2002","journal-title":"J Epilepsy Res"},{"issue":"3","key":"10.1016\/j.neurol.2018.11.007_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00141-8","article-title":"Are some idiopathic epilepsies disorders of ion channels? A working hypotheses","volume":"41","author":"Hirose","year":"1990","journal-title":"J Epilepsy Res"},{"issue":"S3","key":"10.1016\/j.neurol.2018.11.007_bib0020","first-page":"33","article-title":"Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy","volume":"40","author":"Cock","year":"1999","journal-title":"J Epilepsis"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s004010000301","article-title":"A grading system for hippocampal sclerosis Based on the degree of hippocampal mossy fiber sprouting","volume":"101","author":"Proper","year":"2001","journal-title":"J Acta Neuropathol (Ber)"},{"key":"10.1016\/j.neurol.2018.11.007_bib0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5","article-title":"Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice","volume":"32","author":"Penkowa","year":"1990","journal-title":"J Glia"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"Samuel Berkovic, Giuseppe Capovilla et. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Ingrid","year":"2017","journal-title":"Epilepsia"},{"first-page":"147","year":"2004","series-title":"World Health Organization Classification Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs","key":"10.1016\/j.neurol.2018.11.007_bib0040"},{"issue":"4\u20136","key":"10.1016\/j.neurol.2018.11.007_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000185477","article-title":"Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group","volume":"47","author":"Angeli","year":"1997","journal-title":"Horm Res"},{"issue":"8","key":"10.1016\/j.neurol.2018.11.007_bib0050","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/archsurg.137.8.948","article-title":"Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms","volume":"137","author":"Kebebew","year":"2002","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp-2012-303028","article-title":"Neurological manifestations of phaeochromocytomas and secretory paragangliomas: areappraisal","volume":"84","author":"Anderson","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2018.11.007_bib0060","first-page":"970","article-title":"Case records of the Massachusetts General Hospital, Case 15-1988","volume":"318","author":"Scully","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.1966.03110100062014","article-title":"The neurologist's experience with pheochromocytoma. A review of 100 cases","volume":"197","author":"Thomas","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2018.11.007_bib0070","series-title":"Clinical autonomic disorders","first-page":"750","article-title":"Episodic adrenergic syndromes: pheochromocytoma, pseudopheochromocytoma, mastocytosis and carcinoid tumors","author":"Eisenhofer","year":"2008"},{"key":"10.1016\/j.neurol.2018.11.007_bib0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.amjhyper.2005.06.026","article-title":"The vagaries of pheochromocytomas","volume":"18","author":"Manger","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.neurol.2018.11.007_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10253890701395896","article-title":"Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice","volume":"10","author":"Zelinka","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.neurol.2018.11.007_bib0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022981801344","article-title":"Pheochromocytoma as an endocrine emergency","volume":"4","author":"Brouwers","year":"2003","journal-title":"Rev Endocr Metab Dis"},{"key":"10.1016\/j.neurol.2018.11.007_bib0090","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.neurol.2018.11.007_bib0095","first-page":"354","article-title":"Prevalence of clinically unsuspected phaeochromocytoma","volume":"56","author":"St. John Sutton","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neurol.2018.11.007_bib0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.seminoncol.2010.10.017","article-title":"Metastatic paraganglioma","volume":"37","author":"Fliedner","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.410080102","article-title":"Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood\u2013brain interface","volume":"8","author":"Hardebo","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0110","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1471-4159.2010.07065.x","article-title":"Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures","volume":"115","author":"Clinckers","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2018.11.007_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-2999(87)90690-X","article-title":"Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal-like seizures","volume":"135","author":"Micheletti","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07214.x","article-title":"Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model","volume":"117","author":"Raedt","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2018.11.007_bib0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(02)01536-4","article-title":"Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"442","author":"De Sarro","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/seiz.2001.0644","article-title":"Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers","volume":"11","author":"Fischer","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2018.11.007_bib0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0091-3057(01)00654-2","article-title":"Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock","volume":"71","author":"Luchowska","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"18","key":"10.1016\/j.neurol.2018.11.007_bib0140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3171\/jns.1961.18.6.0843","article-title":"Segmental cerebral arterial constriction associated with pheochromocytoma. Report of a case with arteriograms","volume":"196","author":"Armstrong","year":"1961","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neurol.2018.11.007_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(77)90188-1","article-title":"Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol","volume":"42","author":"Saelens","year":"1977","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00004691-199204010-00004","article-title":"Neurotransmitter actions in the thalamus and cerebral cortex","volume":"9","author":"McCormick","year":"1992","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/jn.00943.2007","article-title":"Alpha2-adrenergic receptors modify dendritic spike generation via HCN channels in the prefrontal cortex","volume":"99","author":"Barth","year":"2008","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neurol.2018.11.007_bib0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(87)90628-8","article-title":"Noradrenaline blocks potassium conductance in rat dentate granule cells in vitro","volume":"78","author":"Haas","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2018.11.007_bib0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3940(85)90593-2","article-title":"Effects of noradrenaline on some potassium currents in CA1 neurones in rat hippocampal slices","volume":"60","author":"Sah","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2018.11.007_bib0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0896-6273(95)90047-0","article-title":"Channels underlying the slow after hyperpolarization in hippocampal pyramidal neurons: neurotransmitters modulate the open probability","volume":"15","author":"Sah","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2018.11.007_bib0180","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0896-6273(93)90216-E","article-title":"PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons","volume":"11","author":"Pedarzani","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2018.11.007_bib0185","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuroscience.2004.04.030","article-title":"The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors","volume":"126","author":"Szot","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2018.11.007_bib0190","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0022-3565(24)29473-8","article-title":"Alpha(1) and beta(2) adrenoreceptor agonists inhibit pentylenetetrazole-induced seizures in mice lacking norepinephrine","volume":"298","author":"Weinshenker","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neurol.2018.11.007_bib0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2010.04.011","article-title":"Is elevated norepinephrine an etiological factor in some cases of epilepsy?","volume":"19","author":"Fitzgerald","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2018.11.007_bib0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2018.11.007_bib0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ajcp\/72.2.175","article-title":"Deficiency of dopamine- beta-hydroxylase. A new mechanism for normotensive pheochro- mocytomas","volume":"72","author":"Feldman","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0210","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurol.2018.11.007_bib0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/08037050152669729","article-title":"Dopamine and dopa urinary excretion in patients with pheochro- mocytoma: diagnostic implications","volume":"10","author":"Januszewicz","year":"2001","journal-title":"Blood Press"},{"key":"10.1016\/j.neurol.2018.11.007_bib0220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","article-title":"Pheochromocytomas: can malignant potential be predicted?","volume":"53","author":"John","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.neurol.2018.11.007_bib0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4522(90)90314-T","article-title":"Dopamine D1 receptor modulation of pilocarpine- induced convulsions","volume":"34","author":"Barone","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2018.11.007_bib0230","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/hipo.22327","article-title":"Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits","volume":"24","author":"Gangarossa","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurol.2018.11.007_bib0235","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neuropharm.2008.02.011","article-title":"Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1\/2 and GluR1-AMPA signalling","volume":"54","author":"O'sullivan","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurol.2018.11.007_bib0240","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1523\/JNEUROSCI.20-22-08643.2000","article-title":"Neuroprotective role of dopamine against hippocampal cell death","volume":"20","author":"Bozzi","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.11.007_bib0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tins.2006.01.002","article-title":"Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?","volume":"29","author":"Bozzi","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2018.11.007_bib0250","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/WNR.0b013e32833d5891","article-title":"Kainic acid-induced seizures activate GSK-3beta in the hippocampus of D2R\u2212\/\u2212 mice","volume":"21","author":"Tripathi","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurol.2018.11.007_bib0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2009.06.015","article-title":"Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems","volume":"36","author":"Micale","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2018.11.007_bib0260","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0169-328X(01)00240-6","article-title":"Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat","volume":"94","author":"Deransart","year":"2001","journal-title":"Brain Res Mol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0265","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1523\/JNEUROSCI.21-11-03756.2001","article-title":"Dopamine D4 receptor-deficient mice display cortical hyperexcitability","volume":"21","author":"Rubinstein","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.11.007_bib0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/syn.20225","article-title":"Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor \u201cknockouts\u201d: identification of D4:D1-like interactions","volume":"59","author":"O'sullivan","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neurol.2018.11.007_bib0275","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurol.2018.11.007_bib0280","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004728-198903000-00023","article-title":"MR demonstration of reversible brain abnormalities in eclampsia","volume":"13","author":"Schwaighofer","year":"1989","journal-title":"J Comput Assist Tomogr"},{"issue":"10","key":"10.1016\/j.neurol.2018.11.007_bib0285","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/archneur.1988.00520340032007","article-title":"Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions","volume":"45","author":"Hauser","year":"1988","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2018.11.007_bib0290","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2214\/ajr.166.3.8623651","article-title":"Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity","volume":"166","author":"Appignani","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0295","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410400406","article-title":"Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)","volume":"40","author":"Small","year":"1996","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0300","first-page":"651","article-title":"MR imaging of reversible cyclosporin A-induced neurotoxicity","volume":"12","author":"Truwit","year":"1991","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0305","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00007890-200002270-00001","article-title":"Immunosuppressive-associated leukoencephalopathy in organ transplant recipients","volume":"69","author":"Singh","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.neurol.2018.11.007_bib0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1385\/NCC:2:3:303","article-title":"Neuropathological correlates of reversible posterior leukoencephalopathy","volume":"2","author":"Schiff","year":"2005","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.neurol.2018.11.007_bib0315","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski WS:","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0320","first-page":"825","article-title":"Hemodynamic and permeability changes in posterior reversible enceph alopathy syndrome measured by dynamic susceptibility perfusion weighted MR imaging","volume":"26","author":"Brubaker","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0325","doi-asserted-by":"crossref","first-page":"541","DOI":"10.33588\/rn.3806.2003147","article-title":"Reversible posterior leucoencephalopathy syndrome a case report and review of its physiopathology based on neuroradiological findings","volume":"38","author":"Alurralde","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0330","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/S0004-282X2001000500024","article-title":"Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation","volume":"59","author":"Teive","year":"2001","journal-title":"Arq Neropsiquiatr"},{"key":"10.1016\/j.neurol.2018.11.007_bib0335","first-page":"505","article-title":"Reversible posterior leucoencephalopathy due to hypercalcaemia","volume":"150","author":"Klomp","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.neurol.2018.11.007_bib0340","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.60.5.534","article-title":"Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis","volume":"60","author":"Primavera","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurol.2018.11.007_bib0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/088307389901400502","article-title":"Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome","volume":"14","author":"Pavlakis","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0350","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00467-003-1243-9","article-title":"Is reversible posterior leucoencephalopathy with severe hypertension completely reversible in all patients","volume":"18","author":"Prasad","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.neurol.2018.11.007_bib0355","first-page":"1","article-title":"Hypertensive cncephalopathy","volume":"6","author":"Sharifan","year":"2012","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0360","series-title":"Nelson textbook of pediatrics","first-page":"1639","article-title":"Systemic hypertension","author":"Lande","year":"2011"},{"key":"10.1016\/j.neurol.2018.11.007_bib0365","series-title":"Pediatric nephrology","first-page":"1460","article-title":"Epidemiology of hypertension","author":"Awazu","year":"2009"},{"key":"10.1016\/j.neurol.2018.11.007_bib0370","series-title":"Pediatric nephrology","first-page":"1485","article-title":"Pathophysiology of hypertension","author":"Yamaguchi","year":"2009"},{"key":"10.1016\/j.neurol.2018.11.007_bib0375","series-title":"Pediatric nephrology","first-page":"1519","article-title":"Evaluation of hypertension in childhood diseases","author":"Brewer","year":"2009"},{"key":"10.1016\/j.neurol.2018.11.007_bib0380","series-title":"Pediatric nephrology","first-page":"1457","article-title":"Management of the hypertensive child","author":"Ellis","year":"2009"},{"key":"10.1016\/j.neurol.2018.11.007_bib0385","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archneurol.2011.68","article-title":"Reversible cerebral vasoconstriction syndromes. Analysis of 139 cases","volume":"68","author":"Singhal","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0390","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0395","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1745-7599.2007.00292.x","article-title":"Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric and obstetric critical care","volume":"20","author":"McCoy H:","year":"2008","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.neurol.2018.11.007_bib0400","first-page":"1","article-title":"The international classifi cation of headache disorders","volume":"24","author":"Headache classification subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2018.11.007_bib0405","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-146-1-200701020-00007","article-title":"Narrative review: reversible cerebral vasoconstriction syndromes","volume":"146","author":"Calabrese","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0410","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1468-2982.1999.019002118.x","article-title":"Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm","volume":"19","author":"Dodick","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2018.11.007_bib0415","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1586\/ern.11.112","article-title":"Reversible cerebral vasoconstriction syndrome: current and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neurol.2018.11.007_bib0420","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/B978-0-7020-4088-7.00111-5","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"121","author":"Ducros","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0425","doi-asserted-by":"crossref","first-page":"e18024","DOI":"10.1371\/journal.pone.0018024","article-title":"Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.11.007_bib0430","unstructured":"Tariq Hammad LC, Uchino K, Seby J, Stillman M, Tepper S, Erzurum S, et al. Hajj-Ali Enothelin-1 plays a role in the pathogenesis of Reversible Cerebral Vasoconstriction Syndrome. [Original research]. American College of Rheumatology, Annual Meeting, [Abstract] 2013. First study to suggest a role for endothelin-1 in the pathogensis of RCVS."},{"key":"10.1016\/j.neurol.2018.11.007_bib0435","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21951","article-title":"Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes","volume":"67","author":"Chen","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0440","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/STROKEAHA.109.572313","article-title":"Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors","volume":"41","author":"Ducros","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2018.11.007_bib0445","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/brain\/awm256","article-title":"The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients","volume":"130","author":"Ducros","year":"2007","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2018.11.007_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2016.12.021","article-title":"Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage: a rare cause of postpartum seizure","volume":"35","author":"Lee","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0455","first-page":"2163","article-title":"Acute benign cerebral angiopathy: 6 cases","volume":"12","author":"Rousseaux","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0460","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.STR.19.9.1159","article-title":"Reversible cerebral segmental vasoconstriction","volume":"19","author":"Call","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2018.11.007_bib0465","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archneur.61.3.411","article-title":"Postpartum angiopathy with reversible posterior leukoencephalopathy","volume":"61","author":"Singhal","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0470","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12028-007-0058-0","article-title":"Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage","volume":"7","author":"Edlow","year":"2007","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.neurol.2018.11.007_bib0475","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jocn.2010.07.103","article-title":"Delayed angiographic changes in postpartum cerebral angiopathy","volume":"18","author":"Ghia","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2018.11.007_bib0480","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3174\/ajnr.A4214","article-title":"Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course","volume":"36","author":"Miller","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0485","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/STROKEAHA.111.639575","article-title":"Variable presentations of postpartum angiopathy","volume":"43","author":"Fugate","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2018.11.007_bib0490","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF03008459","article-title":"The anaesthetic management of a patient with a pheochromocytoma and acute stroke","volume":"38","author":"Fox","year":"1991","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.neurol.2018.11.007_bib0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0167-5273(95)02302-D","article-title":"Adrenal tumour, congestive heart failure and hemiparesis in an 18-year-old male. A clinical-pathological conference","volume":"49","author":"Goswami","year":"1995","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.neurol.2018.11.007_bib0500","first-page":"509","article-title":"Phaeochromocytoma and paraganglioma","volume":"7","author":"Fonseca","year":"1993","journal-title":"Clin. Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.neurol.2018.11.007_bib0505","first-page":"76","article-title":"Carmoxirole inhibits platelet aggregation in vitro and ex vivo","volume":"33","author":"Kirsten","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.neurol.2018.11.007_bib0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0140-6736(92)90347-6","article-title":"Pathophysiology of acute ischaemic stroke","volume":"339","author":"Pulsinelli","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2018.11.007_bib0515","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.59.7.1028","article-title":"Reduced inhibition within primary motor cortex in patients with poststroke focal motor seizures","volume":"59","author":"Kessler","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2018.11.007_bib0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0361-9230(02)00768-2","article-title":"Epileptiform spikes desynchronize and diminish fast (gamma) activity of the brain. An \u201canti-binding\u201d mechanism?","volume":"58","author":"Medvedev","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurol.2018.11.007_bib0525","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/pgmj.2005.041426","article-title":"Post-stroke seizure and post-stroke epilepsy","volume":"82","author":"Myint","year":"2006","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.neurol.2018.11.007_bib0530","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jnr.23836","article-title":"Prospects of modeling poststroke epileptogenesis","volume":"95","author":"Reddy","year":"2017","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.neurol.2018.11.007_bib0535","first-page":"313","article-title":"Disappearance of epilepsy after resection of catecholamine secreting extra-adrenal paragangliomas: a case report","volume":"71","author":"Purmer","year":"2013","journal-title":"Neth J Med"},{"key":"10.1016\/j.neurol.2018.11.007_bib0540","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1538574408323847","article-title":"Cessation of epilepsy in an 8-year-old girl following removal of carotid body paraganglioma","volume":"43","author":"Wall","year":"2009","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.neurol.2018.11.007_bib0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.jhh.1001499","article-title":"Seizure as a presenting symptom of phaeochromocytoma in a young soldier","volume":"17","author":"Leiba","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.neurol.2018.11.007_bib0550","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1460-9592.2006.02143.x","article-title":"Anesthesia management of a ganglioneuroma with seizure presenting as pheochromocytoma","volume":"17","author":"Batra","year":"2007","journal-title":"Pediatr Anesth"},{"key":"10.1016\/j.neurol.2018.11.007_bib0555","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.10.2011.4922","article-title":"Undiagnosed phaeochromocytoma masquerading as eclampsia","volume":"2012","author":"Petrie","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.neurol.2018.11.007_bib0560","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1526-4610.2008.01154.x","article-title":"PRES following administration of DHE in a patient with unsuspected pheochromocytoma","volume":"48","author":"Brendan","year":"2008","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.neurol.2018.11.007_bib0565","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4097\/kjae.2012.63.6.555","article-title":"Dexmedetomidine and remifentanil in the perioperative management of an adolescent undergoing resection of pheochromocytoma \u2013 A case report","volume":"63","author":"Jung","year":"2012","journal-title":"Korean J Anesthesiol"},{"issue":"I","key":"10.1016\/j.neurol.2018.11.007_bib0570","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/bjs.1800540118","article-title":"Association of a phaeochromocytoma and cerebral gliosarcoma WITH neurofibromatosis","volume":"54","author":"Roberts","year":"1967","journal-title":"Brit J Surg"},{"issue":"6","key":"10.1016\/j.neurol.2018.11.007_bib0575","first-page":"257","article-title":"Index of Suspicion. Case 1: status epilepticus, hypertension, and tachycardia in a 5-year-old boy. Case 2: cardiopulmonary arrest during gymnastics practice in a teenage girl. Case 3: acute renal failure in a teenage boy who has autism and pica","volume":"32","author":"Chartan","year":"2011","journal-title":"Pediatr Rev"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718305691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718305691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:39:22Z","timestamp":1758519562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378718305691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0035378718305691"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2018.11.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures in patients with a phaeochromocytoma\/paraganglioma (PPGL): A review of clinical cases and postulated pathological mechanisms","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}